Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, January 2, 2020
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
[ Thu, Jan 02nd 2020
] - WOPRAI
Tue, December 31, 2019
[ Tue, Dec 31st 2019
] - WOPRAI
[ Tue, Dec 31st 2019
] - WOPRAI
[ Tue, Dec 31st 2019
] - WOPRAI
Mon, December 30, 2019
[ Mon, Dec 30th 2019
] - WOPRAI
Raghuram Selvaraju Maintained (AXSM) at Strong Buy with Increased Target to $200 on, Dec 30th, 2019
Raghuram Selvaraju of HC Wainwright & Co., Maintained "Axsome Therapeutics, Inc." (AXSM) at Strong Buy with Increased Target from $170 to $200 on, Dec 30th, 2019.
Raghuram has made no other calls on AXSM in the last 4 months.
There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Raghuram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Raghuram
- Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $158 on, Monday, December 16th, 2019
Similar Stocks and Investing Articles
[ Tue, Dec 17th 2019
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Mon, Dec 16th 2019
] - WOPRAI
[ Thu, Dec 12th 2019
] - WOPRAI
[ Wed, May 29th 2019
] - WOPRAI
[ Tue, Apr 09th 2019
] - WOPRAI
[ Wed, May 23rd 2018
] - WOPRAI
[ Tue, Jan 30th 2018
] - WOPRAI
[ Fri, Jan 26th 2018
] - WOPRAI
[ Fri, Oct 06th 2017
] - WOPRAI